BioSpace News Archive

US Capital Global Securities LLC , an affiliate of US Capital Global , recently launched an investment opportunity of up to $5 million in Canadian health science pioneer Andira Pharmaceuticals (“Andira” or the “Company”). Andira has announced that it has received a Notice of Allowance from the United States Patent & Trademark Office (USPTO) for US Patent Application No. 17/589,588 “Antibiotic Cannabinoid-Terpene Formulatioins.”

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS MedTech, Tools and Genomics Summit 2023 in Dana Point, CA , on Tuesday, August 15, 2023, which includes a presentation beginning at 3:00 pm PT.

Karius ® , Inc. a world leader in liquid biopsy for infectious diseases, is announcing the appointment of two healthcare veterans to its Board of Directors: Norman (Ned) Sharpless, M.D. and Elizabeth (Liz) O’Farrell.

Rhinostics has been selected to exhibit its RHINOstic® Automated Swab platform at the Vizient Innovative Technology Exchange.

AceLink Therapeutics, Inc. announced the opening of the first clinical trial site in China for its Phase 2, open‑label study of the safety, pharmacokinetics, pharmacodynamics and preliminary measures of physiological efficacy of AL01211 in males with classic Fabry disease who have not been previously treated with other Fabry disease therapies.

Modular Medical, Inc. today announced that Jeb Besser, CEO, is scheduled to present at the Sidoti Micro-Cap Virtual Conference on August 17.

Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced financial results for the second quarter ended June 30, 2023.

Arcutis Biotherapeutics, Inc. and Hangzhou Zhongmei Huadong Pharmaceutical Co, a wholly owned subsidiary of Huadong Medicine Co., Ltd., announced that the companies have entered into a strategic collaboration and licensing agreement for the development, manufacture, and commercialization of topical roflumilast in Greater China and Southeast Asia.

Molecular Templates, Inc. today reported financial results and business updates for the second quarter of 2023.

Microbot Medical Inc., the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system, announces the expansion of its global team of experts supporting the Company as scientific advisory board members, with Francois H. Cornelis, MD, PhD joining Microbot’s SAB.